Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Dual-action antiatherosclerotic agents in the Sankyo pipeline

April 27, 1999

China Pharmaceutical University develops effective antiarrhythmic agents

April 27, 1999

Vasodilating benzamide and cinnamide derivatives from China

April 27, 1999

Another series of HDL-increasing compounds revealed by American Home Products

April 27, 1999

Selective ETB antagonist A-192621 used to explore role of ETB in blood pressure regulation

April 26, 1999

Boehringer Ingelheim announces German launch of angiotensin II blocker

April 26, 1999

BASF claims series with mixed ETA/ETB-antagonist properties

April 26, 1999

HDL-increasing compounds claimed by AHP for cardiovascular disease, dyslipoproteinemia

April 26, 1999

News from FASEB: RC-522 provides cardioprotection without prodysrhythmic effects

April 26, 1999

Proteasome inhibitor PS-519 demonstrates cardioprotective activity in preclinical model

April 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...